Intriguingly, Wang et al. discovered that LINC01089 inhibits the development and progression of NSCLC by suppressing the miR-27a-SFRP1-Wnt/β-catenin-EMT pathway. Here, LINC01089 is linked to non-small cell lung carcinoma.